Public Forum
Default group for all members. Biological family sometimes get you down? Come join your logical family!
Organizers:
- Organized by
-
-
The Marketing of Statins
-
The Marketing of Statins
I understand that back in the 1970s, doctors weren’t routinely screening for high cholesterol, and levels up to around 300 mg/dL were often still considered within a normal range.
Then in 1984, the National Institutes of Health launched the National Cholesterol Education Program, around the same time pharmaceutical companies were developing the first statin drugs, like Lovastatin in 1987.
From there, guidelines from organisations like the American Heart Association and the American College of Cardiology gradually lowered the threshold for what’s considered “high” cholesterol.
And coincidentally …the new guidelines happened when big pharma became involved in research, education, and guideline development.
The outcome?
👉 Millions more people suddenly became candidates for cholesterol-lowering medication. And as Dr. Marik says in his latest substack (link in comments) despite decades of aggressive cholesterol lowering, coronary artery disease remains the leading cause of death worldwide.
Dr. Marik goes on to ask:
What if coronary artery disease is not primarily a cholesterol disease at all?
What if it is, instead, a disorder of metabolism—driven by insulin resistance, chronic inflammation, and energy dysregulation at the cellular level?
If that is true—and the evidence increasingly suggests that it is—then our entire framework for prevention and treatment needs to change.
-
1 Reply
-
Dr. Marik’s substack https://paulmarik.substack.com/p/the-cholesterol-myth-is-crumblingand
Log in to reply.